Population
In vitro translation assay programmed with virion RNA and FMDV-infected cells
Design
Preclinical
Authors
Loading...
E-64 compounds merit preclinical antiviral development for FMDV; leaves open translation to natural hosts or clinical use.
E-64-based compounds demonstrate antiviral effects against foot-and-mouth disease virus by inhibiting viral protease activity and reducing virus yield in vitro.
Kleina et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: